RVMD — Revolution Medicines Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousLarge CapNeutral

Annual balance sheet for Revolution Medicines, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	441	577	645	1,853	2,289
Net Total Accounts Receivable
Net Total Receivables	6.39	5.93	4.67	1.25	0
Prepaid Expenses
Total Current Assets	454	590	660	1,879	2,328
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	36.3	71.2	73.7	100	142
Net Goodwill
Net Intangible Assets
Other Long Term Assets
Total Assets	567	738	812	2,062	2,558
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	47.2	60.4	62	144	164
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	92.7	135	127	236	293
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Unrealized Gain / Loss
Total Equity	475	603	685	1,826	2,265
Total Liabilities & Shareholders' Equity	567	738	812	2,062	2,558
Total Common Shares Outstanding